Companies / India
Mylan To Buy India's Matrix Laboratories
August 2006 | FDI AlertIn the largest acquisition in the Indian pharmaceuticals sector to date, US generic drug manufacturer Mylan has announced that it is to acquire control of Indian firm Matrix Laboratories for an estimated US$735mn. The purchase is expected to win the US firm significant new markets in Africa, South Asia, China and Western Europe, and illustrates the globalising trend seen among North American generic manufacturers in recent
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
